Çağlar Ahmet, Kaçer İlker
Department of Emergency Medicine, Aksaray University Training and Research Hospital, Aksaray, Turkey.
Psychol Health Med. 2022 Jan;27(1):228-236. doi: 10.1080/13548506.2021.1876893. Epub 2021 Jan 25.
The COVID-19 related high morbidity and mortality have led to a common fear and anxiety. This study aimed to determine the state/trait and death anxiety levels of patients with myocardial infarction (MI) and COVID-19 pneumonia. The study was conducted at the emergency department of a tertiary hospital in Central Anatolia of Turkey. 120 patients with myocardial infarction , 120 patients with COVID-19 pneumonia, and 120 healthy volunteers as a control group were included in the study. The participants filled out the questionnaire that included the State-Trait Anxiety Inventory (STAI) and the Thorson-Powell's Revised Death Anxiety Scale (RDAS). All scores of patient groups were significantly higher than the control group. There was no significant difference in terms of STAI-S, STAI-T, and RDAS scores between COVID-19 pneumonia and MI groups. The anxiety risk increased 2.14-fold for STAI-T and 1.97-fold for STAI-S in patients with COVID-19 pneumonia compared to the control group. In this study, the state/trait and death anxiety levels of patients with COVID-19 pneumonia were as high as patients with myocardial infarction.COVID-19 pneumonia-related anxiety was associated with chronic diseases and smoking. Knowing the level of anxiety in these patients is important to provide better health services in the emergency departments.
与新冠病毒病（COVID-19）相关的高发病率和死亡率引发了普遍的恐惧和焦虑。本研究旨在确定心肌梗死（MI）合并COVID-19肺炎患者的状态/特质焦虑及死亡焦虑水平。该研究在土耳其中部安纳托利亚一家三级医院的急诊科进行。研究纳入了120例心肌梗死患者、120例COVID-19肺炎患者以及120名健康志愿者作为对照组。参与者填写了包含状态-特质焦虑量表（STAI）和索尔森-鲍威尔修订版死亡焦虑量表（RDAS）的问卷。所有患者组的得分均显著高于对照组。COVID-19肺炎组和心肌梗死组在STAI-S、STAI-T及RDAS得分方面无显著差异。与对照组相比，COVID-19肺炎患者的STAI-T焦虑风险增加了2.14倍，STAI-S焦虑风险增加了1.97倍。在本研究中，COVID-19肺炎患者的状态/特质焦虑及死亡焦虑水平与心肌梗死患者一样高。与COVID-19肺炎相关的焦虑与慢性病和吸烟有关。了解这些患者的焦虑水平对于在急诊科提供更好的医疗服务很重要。
